MID TO LARGE BIOPHARMA
As portfolios scale,
your precision matters
TA Scan's enterprise-ready intelligence helps sponsors design realistic studies, avoid protocol amendments, and choose sites with capacity to enroll.
Deliver Insight, Faster
Accelerate study planning with deep, validated data across global portfolios.
Reduce Trial Risk
Prevent delays by predicting recruitment challenges, site issues, and saturation early.
Scale across indications
Standardize feasibility and site selection across divisions, markets, and study teams.
Before/After
Why pharma choose TA Scan?

Flexible intelligence that fits your planning workflow.
Deliver studies faster, with fewer amendments and stronger pipeline execution.
Validate protocols with real data
Forecast enrollment timelines
Find high-capacity sites & PIs
Avoid competition & delays

95%
Operational Confidence
Capacity signals helped teams make better decisions and reduce enrollment risk.
2.5M+
Investigator profiles
Global, continuously updated coverage across therapeutic areas, and study phases.
>100 hrs
Saved per study
Teams report saving up to 2.5 weeks in feasibility planning time.

Blog
Company News & Insights
Get product updates, expert perspectives, and clinical operations guidance from the TA Scan team.
Learn more

Case study
The TA Scan Feasibility Guide
Learn how leading teams use data to validate protocols, forecast timelines, and select the right investigators and sites.
Access Guides

On-demand Webinars
Expert Webinars
Integrated tutorials and videos show how to use TA Scan for feasibility, KOL analysis and competitive intelligence.
Watch Webinars










